Recent progress in antiviral chemotherapy for respiratory syncytial virus infections.
about
RFI-641, a potent respiratory syncytial virus inhibitor.An update on respiratory syncytial virus antiviral agents.RhoA-derived peptide dimers share mechanistic properties with other polyanionic inhibitors of respiratory syncytial virus (RSV), including disruption of viral attachment and dependence on RSV G
P2860
Recent progress in antiviral chemotherapy for respiratory syncytial virus infections.
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Recent progress in antiviral chemotherapy for respiratory syncytial virus infections.
@ast
Recent progress in antiviral chemotherapy for respiratory syncytial virus infections.
@en
type
label
Recent progress in antiviral chemotherapy for respiratory syncytial virus infections.
@ast
Recent progress in antiviral chemotherapy for respiratory syncytial virus infections.
@en
prefLabel
Recent progress in antiviral chemotherapy for respiratory syncytial virus infections.
@ast
Recent progress in antiviral chemotherapy for respiratory syncytial virus infections.
@en
P2860
P356
P1476
Recent progress in antiviral chemotherapy for respiratory syncytial virus infections.
@en
P2093
P2860
P304
P356
10.1517/13543784.9.2.221
P407
P577
2000-02-01T00:00:00Z